0001564590-20-046576.txt : 20201117 0001564590-20-046576.hdr.sgml : 20201117 20201015211651 ACCESSION NUMBER: 0001564590-20-046576 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLUS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001095981 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330827593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 BUSINESS PHONE: 737.255.7194 MAIL ADDRESS: STREET 1: 4200 MARATHON BLVD. STREET 2: SUITE 200 CITY: AUSTIN STATE: TX ZIP: 78756 FORMER COMPANY: FORMER CONFORMED NAME: CYTORI THERAPEUTICS, INC. DATE OF NAME CHANGE: 20050712 FORMER COMPANY: FORMER CONFORMED NAME: MACROPORE INC DATE OF NAME CHANGE: 20010320 CORRESP 1 filename1.htm pstv-corresp.htm

 

PLUS THERAPEUTICS, INC.

4200 Marathon Blvd., Suite 200

Austin, Texas 78756

 

October 15, 2020

 

VIA FACSIMILE AND EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

       Re:

Plus Therapeutics, Inc. - Registration Statement – Form S-3

 

File No. 333-249410

 

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Plus Therapeutics, Inc. (the “Registrant”) hereby requests that the effective date of the above-referenced registration statement on Form S‑3 (File No. 333-249410) (the “Registration Statement”) be declared effective on October 19, 2020, at 5:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Davina K. Kaile and Nicholas Griffin of Pillsbury Winthrop Shaw Pittman LLP, counsel to the Registrant, to make such request on its behalf.

Once the Registration Statement has been declared effective, please orally confirm that event with Davina K. Kaile of Pillsbury Winthrop Shaw Pittman LLP, counsel to the Registrant, at (650) 233-4564, or in her absence, Nicholas Griffin at (713) 276-7628.

 

[Signature Page Follows]

 

 

 

 

 

 

    

Sincerely,

 

 

PLUS THERAPEUTICS, INC.

 

 

    By:

/s/ Marc H. Hedrick, MD

 

Marc H. Hedrick, MD

 

President and Chief Executive Officer

 

   cc:

Andrew Sims

 

Davina K. Kaile, Esq.